Farmavita.Net member is developing innovative concept for glogal branding and distribution of remedies and devices for therapy of arthritis.
Company is looking to joint-venture, collaborative development or in-licensing of non-prescrition products, on exclusive basis.
For more details please contact Farmavita.Net.
Farmavita has developed Renarthro, the synergistic combination of frankincense and myrrh extracts, with Osteol. Renarthro is formulated into capsules, ice-gel and honey. This unique innovative product is available for exclusive licensing or distributorship, for selected markets. Product details are available at www.renarthro.com or please send inquiry to firstname.lastname@example.org.
Farmavita.Net member is looking for OTC medicatios against vaginal infections. Product should be approved in EU and have up-to-date CTD Dossier. Licensee will also close exclusive supply agreement with licensor.
Examples of suitable products are monoproducts or combinations of fluconazole, itraconacole, clindamycine pessaries and cream, as well as smiilar products.
WE REQUIRE PLANT PROVEN COMMERCIAL TECHNOLOGY TO MANAUFACTURE SPECTINOMYCIN HCL IN INDIA . TECHNOLOGY LICENCENSORS/MANUFACTURING COMPANIES/CONSULTANTS TO SUBMIT THEIR TECHNICAL AND COMMERCIAL PROFILE AND BUSINESS TERMS.
CONTACT; MR.ARVIND GANDHI -GM MKTG ( API AND FINE CHEMICALS) ASENCE PHARMA PVT.LTD.,MUMBAI.
The gradual spread of software automation in drug development may be getting a boost from open source systems. Most e-clinical systems today--from data capture and storage to trial management and operations--are proprietary, despite the excellent work that solutions providers have done to make their products compatible with existing standards-based and de facto standard industry systems.
Micro- and nanoscale technologies are emerging as powerful enabling tools for tissue engineering and drug discovery. In tissue engineering, micro- and nanotechnologies can be used to fabricate biomimetic scaffolds with increased complexity and vascularization.
The whole 16 pages article is available for download at Downloads section of Farmavita.Net.
18-19th June, Frankfurt, Germany
The game in the chemical sales and marketing sector has changed over the past couple of years since processes have become faster and competition sharper. Also, as customers are becoming even more influential and empowered in making decisions, the need for change has never been more critical. Only those who adapt to the current challenging chemistry landscape will prove their readiness to compete successfully.
This report gives a thorough analysis of the refurbished medical devices market segment. The regulatory environment for refurbished devices is assessed in 92 countries. Opportunities within this market are assessed by device type and by country. A thorough analysis of who the end users for refurbished devices are and what their demands are, with strategies and best practices for growth discussed.
The leader shows that style is no substitute for substance, that creating an impression is not more potent than acting from one's center.